Lilly Statement on Indiana Biosciences Research Institute
INDIANAPOLIS, May 30, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has issued the following statement from Senior Vice President Bart Peterson regarding today's announcement introducing the Indiana Biosciences Research Institute:
"The Indiana Biosciences Research Institute will change the bio-landscape of our region. Indiana's life sciences companies spend billions of dollars in research and development each year to advance health care innovations for improved human health. The Institute will help us nurture our partnerships across the country and develop more intellectual capital here in Indiana -- allowing us to keep more research dollars in the state, attract more federal research funds, and draw top scientific minds to feed our research pipeline and local economies.
"For years, Indiana has been a life sciences leader. We have roughly 2,000 companies, big and small, that focus on life sciences in our state. Our biopharmaceutical companies, agricultural science companies, device and diagnostic companies, and world-class universities have collectively pushed Indiana to the front of the line as a life sciences hub. Moving forward, the institute will help us tear down silos and bring our organizations together – benefitting patients who desperately need better solutions for emerging diseases and other difficult health care challenges.
"This institute is unique because Lilly and other private sector companies are partnering with state government and three major universities to support its creation – and it will make all Hoosier bioscience companies, including Lilly, even stronger. An impressive roster of collaborators, an environment that attracts national and international talent, and an infrastructure that allows us to build a deeper library of intellectual property will separate Indiana from other states attempting to replicate our success.
"A decade ago, BioCrossroads helped Indiana become a more attractive place for life sciences companies to do business. Today, we collectively take the next step with the Indiana Biosciences Research Institute."
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information ─ for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com and https://twitter.com/LillyPad_Media. C-LLY
Refer to: (317)432-5195 (m); (317)277-4021 (o) - Greg Kueterman
SOURCE Eli Lilly and Company
More by this Source
Lilly to Participate in Barclays Healthcare Conference
Mar 05, 2014, 16:45 ET
Elanco Announces Agreement to Acquire Lohmann Animal Health
Feb 24, 2014, 08:00 ET
Lilly to Participate in Cowen Healthcare Conference
Feb 21, 2014, 12:30 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.